An essential role of human Ada3 in p53 acetylation (Q40175886)

18 September 2017

An essential role of human Ada3 in p53 acetylation (English)

1 reference

18 September 2017

Alo Nag

1

1 reference

18 September 2017

Aleksandra Germaniuk-Kurowska

2

1 reference

18 September 2017

Manjari Dimri

3

1 reference

18 September 2017

Michael A Sassack

4

1 reference

18 September 2017

Channabasavaiah Basavaraju Gurumurthy

5

1 reference

18 September 2017

Qingshen Gao

6

1 reference

18 September 2017

Goberdhan Dimri

7

1 reference

18 September 2017

Hamid Band

8

1 reference

18 September 2017

Vimla Band

9

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

Journal of Biological Chemistry

18 September 2017

1 reference

18 September 2017

282

1 reference

18 September 2017

12

1 reference

18 September 2017

8812-8820

1 reference

p53 mutations in human cancers

18 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Post-translational modifications and activation of p53 by genotoxic stresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

DNA damage activates p53 through a phosphorylation-acetylation cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Post-translational modification of p53 in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Regulation of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

C-terminal ubiquitination of p53 contributes to nuclear export

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

hADA3 is required for p53 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

ADA3: a gene, identified by resistance to GAL4-VP16, with properties similar to and different from those of ADA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Histone-like TAFs within the PCAF histone acetylase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Mdm2 promotes the rapid degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Regulation of p53 stability by Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

p53 stabilization and transactivation by a von Hippel-Lindau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Acetylation of p53 inhibits its ubiquitination by Mdm2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Gene activation by histone and factor acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Histone acetyltransferase activity and interaction with ADA2 are critical for GCN5 function in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Role of the Ada2 and Ada3 transcriptional coactivators in histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Binding and modulation of p53 by p300/CBP coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Deacetylation of p53 modulates its effect on cell growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

The p53 response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Mechanisms of p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

The ADA complex is a distinct histone acetyltransferase complex in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

Human histone acetyltransferase GCN5 exists in a stable macromolecular complex lacking the adapter ADA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

The homologous Drosophila transcriptional adaptors ADA2a and ADA2b are both required for normal development but have different functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610443200

21 January 2018

Identifiers

DOI

10.1074/JBC.M610443200

1 reference

18 September 2017

1 reference